US 7241581
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC protein
granted A61KA61K38/1709
Quick answer
US patent 7241581 (Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC protein) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jul 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/1709